These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1839689)

  • 1. [Inhibitor of thromboxane A2 synthesis as anticoagulant in hemodialysis].
    Iida N
    Nihon Rinsho; 1991 Dec; 49 Suppl():746-52. PubMed ID: 1839689
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic arterial occlusive diseases--drug therapy and thromboxane A2 synthetase inhibitor].
    Yasuda K; Matsui Y; Goda T; Sakuma M; Go K
    Nihon Rinsho; 1991 Sep; 49(9):2149-54. PubMed ID: 1960880
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of endogenous thromboxane A2 biosynthesis mediates presynaptic inhibition by endothelin-3 of dog stellate ganglionic transmission.
    Kushiku K; Ohjimi H; Yamada H; Kuwahara T; Furukawa T
    J Pharmacol Exp Ther; 1995 Jan; 272(1):70-6. PubMed ID: 7815366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis and pharmacological modulation of thromboxane in humans.
    Patrono C
    Circulation; 1990 Jan; 81(1 Suppl):I12-5; discussion I22-3. PubMed ID: 2136814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological actions of thromboxane A2 and their pharmacological antagonism by thromboxane receptor blockade with GR32191.
    Humphrey PP; Hallet P; Hornby EJ; Wallis CJ; Collington EW; Lumley P
    Circulation; 1990 Jan; 81(1 Suppl):I42-52; discussion I59-60. PubMed ID: 2136817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane synthesis inhibitors and receptor antagonists.
    Patrono C
    Thromb Res Suppl; 1990; 11():15-23. PubMed ID: 2148990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of selective inhibitor of thromboxane synthetase (OKY-046) and thromboxane antagonist (ONO-3708) on ischemia-induced mitochondrial dysfunction in canine heart.
    Ito T; Ito Y; Torii T; Hieda N; Toki Y; Miyazaki Y; Hashimoto H; Ogawa K; Satake T
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():392-6. PubMed ID: 2959085
    [No Abstract]   [Full Text] [Related]  

  • 10. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
    Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thromboxane A2 synthesis inhibitor OKY046 on canine pancreas and kidney preservation.
    Kin S; Stephanian E; Gores P; Moss A; Shinagawa Y; Barrou B; Gruessner R; Tamura K; Sutherland DE
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1627-8. PubMed ID: 8442215
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.
    Hiraku S; Wakitani K; Katsube N; Kawasaki A; Tsuboshima M; Naito J; Ujiie A; Komatsu H; Iizuka K
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():241-4. PubMed ID: 6221530
    [No Abstract]   [Full Text] [Related]  

  • 14. Ridogrel inhibits systemic and renal formation of thromboxane A2 and antagonizes platelet thromboxane A2/prostaglandin endoperoxide receptors upon chronic administration to man.
    Weber C; Beetens JR; Tegtmeier F; Van Rooy P; Vercammen E; Wouters L; De Clerck F
    Thromb Haemost; 1992 Aug; 68(2):214-20. PubMed ID: 1412169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of thromboxane receptor blockade versus thromboxane synthase inhibition on canine arterial graft patency.
    Bech FR; Cronenwett JL; McDaniel MD; Ogletree ML; Freeman DH
    J Vasc Surg; 1990 Aug; 12(2):119-25. PubMed ID: 2143235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thromboxane antagonism in thrombocytes--pathophysiology, pharmacology and possible clinical significance].
    Schrör K
    Wien Klin Wochenschr; 1991; 103(18):543-53. PubMed ID: 1836294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane mediates pulmonary vasoconstriction and contributes to cytotoxicity in pig lungs perfused with fresh human blood.
    Pierson RN; Parker RE
    Transplant Proc; 1996 Apr; 28(2):625. PubMed ID: 8623309
    [No Abstract]   [Full Text] [Related]  

  • 18. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
    [No Abstract]   [Full Text] [Related]  

  • 20. Thromboxane A2 in cardiovascular and renal disorders: is there a defined role for thromboxane receptor antagonists or thromboxane synthase inhibitors?
    Smith EF
    Eicosanoids; 1989; 2(4):199-212. PubMed ID: 2534279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.